Legal & General Group Plc - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 96 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$33,851
-72.4%
13,380
-27.5%
0.00%
Q2 2023$122,871
-33.4%
18,449
+86.7%
0.00%
Q1 2023$184,398
-11.3%
9,882
+2.1%
0.00%
Q4 2022$207,883
+94.3%
9,678
+7.5%
0.00%
Q3 2022$107,000
-6.1%
9,000
+3.5%
0.00%
Q2 2022$114,000
-35.2%
8,699
+3.6%
0.00%
Q1 2022$176,000
+4.1%
8,393
+1.0%
0.00%
Q4 2021$169,000
-32.9%
8,3140.0%0.00%
Q3 2021$252,000
+98.4%
8,314
+91.0%
0.00%
Q2 2021$127,000
-29.1%
4,352
+4.8%
0.00%
Q1 2021$179,000
-8.2%
4,152
-1.7%
0.00%
Q4 2020$195,000
+143.8%
4,224
+129.9%
0.00%
Q3 2020$80,000
-31.0%
1,837
-15.7%
0.00%
Q2 2020$116,000
+383.3%
2,179
+105.2%
0.00%
Q1 2020$24,000
+33.3%
1,062
-13.7%
0.00%
Q4 2019$18,000
+157.1%
1,230
+22.4%
0.00%
Q3 2019$7,000
-36.4%
1,0050.0%0.00%
Q2 2019$11,0001,0050.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
LUMINUS MANAGEMENT LLC 157,099$4,565,0000.66%
ACT CAPITAL MANAGEMENT, LLC 42,000$1,221,0000.63%
Knoll Capital Management, LLC 20,000$581,0000.30%
Artemis Investment Management LLP 1,193,290$34,664,0000.30%
Ghisallo Capital Management LLC 225,000$6,539,0000.25%
Monashee Investment Management LLC 60,000$1,744,0000.21%
AlphaCentric Advisors LLC 25,000$727,0000.20%
CAAS CAPITAL MANAGEMENT LP 232,285$6,750,0000.11%
AllSquare Wealth Management LLC 5,402$157,0000.09%
CNA FINANCIAL CORP 9,479$275,0000.08%
View complete list of BIOXCEL THERAPEUTICS INC shareholders